<p>Time course of blood glucose concentration (<b>A</b>), body weight (<b>B</b>) and paw withdrawal threshold (<b>C</b>) alterations after STZ or citrate buffer (vehicle) treatment. Data are presented as meanS.E.M. (n = 30), **<i>P</i><0.01 <i>vs</i>. vehicle control.</p
<p>Both groups increased their body weights over time (Repeated measures ANOVA, p<0.0001), whereas t...
<p>Data of the experimental models of spontaneously hypertensive rats (SHR) and diabetic nephropathy...
<p>(A) body weight; (B) blood glucose (*<i>P</i> < 0.05, versus Normal; #<i>P</i> < 0.05 versus STZ+...
<p>The injection of STZ induced a significant decrease in body weight and an increase in blood gluco...
<p>P1 rat pups were injected with low doses of streptozotocin in citrate buffer (STZ) or with the co...
a<p>Weight gain was calculated from the difference of values prior and 8 weeks post STZ injection. B...
<p>STZ injection led to a significant stable increase of random blood glucose level (A) and body wei...
The result of rats blood glucose changes in 3 days and 14 days after STZ-injection.</p
<p>(<b>A</b>) Glycemia values and (<b>B</b>) body weight at baseline and 4 weeks post diabetes induc...
<p>Initial (I), Final (F), 48 hours after streptozotocin injection (STZ). Data are mean ± SEM. The n...
<p>Intraperitoneally (IP) injected STZ, at 50 mg/kg, resulted in high blood glucose levels within th...
<p>WT (n = 6) (●), T1DM (n = 6) (○) and T1DM/AFB1 (n = 4) (▼) following buffer alone or STZ treatmen...
<p>(<b>A</b>) Cumulative incidence of diabetes (random-fed blood glucose >250 mg/dl) in CF and Tfm t...
The Streptozotocin- (STZ-) induced diabetic model is widely used; however, unexplained acute toxicit...
Streptozotocin (STZ)-induced diabetes in rats is characterized by cardiovascular dysfunction beginni...
<p>Both groups increased their body weights over time (Repeated measures ANOVA, p<0.0001), whereas t...
<p>Data of the experimental models of spontaneously hypertensive rats (SHR) and diabetic nephropathy...
<p>(A) body weight; (B) blood glucose (*<i>P</i> < 0.05, versus Normal; #<i>P</i> < 0.05 versus STZ+...
<p>The injection of STZ induced a significant decrease in body weight and an increase in blood gluco...
<p>P1 rat pups were injected with low doses of streptozotocin in citrate buffer (STZ) or with the co...
a<p>Weight gain was calculated from the difference of values prior and 8 weeks post STZ injection. B...
<p>STZ injection led to a significant stable increase of random blood glucose level (A) and body wei...
The result of rats blood glucose changes in 3 days and 14 days after STZ-injection.</p
<p>(<b>A</b>) Glycemia values and (<b>B</b>) body weight at baseline and 4 weeks post diabetes induc...
<p>Initial (I), Final (F), 48 hours after streptozotocin injection (STZ). Data are mean ± SEM. The n...
<p>Intraperitoneally (IP) injected STZ, at 50 mg/kg, resulted in high blood glucose levels within th...
<p>WT (n = 6) (●), T1DM (n = 6) (○) and T1DM/AFB1 (n = 4) (▼) following buffer alone or STZ treatmen...
<p>(<b>A</b>) Cumulative incidence of diabetes (random-fed blood glucose >250 mg/dl) in CF and Tfm t...
The Streptozotocin- (STZ-) induced diabetic model is widely used; however, unexplained acute toxicit...
Streptozotocin (STZ)-induced diabetes in rats is characterized by cardiovascular dysfunction beginni...
<p>Both groups increased their body weights over time (Repeated measures ANOVA, p<0.0001), whereas t...
<p>Data of the experimental models of spontaneously hypertensive rats (SHR) and diabetic nephropathy...
<p>(A) body weight; (B) blood glucose (*<i>P</i> < 0.05, versus Normal; #<i>P</i> < 0.05 versus STZ+...
DOI
Add to ORKG